Member Info for Lokbarith

At the time I stood by that, however this was based on the previous views from CG - which was an utter flop.

The new interview actually has some form of basis, it might still fail but there’s at least something in it!

The interview was good, business model makes a little more sense but this company is not gonna sky rocket just yet.

Gradually they’ll hopefully continue to earn and reinvest, the issue being if either TAO or BTC have a major pullback they’re susceptible to losses unless they have cash in hand to buy that dip and level off. That’s what will underpin this, if they can manage the strategy correctly.

Given the impending potential dilution I wouldn’t expect SP to jump, why bother when you can buy at discount when the shares execute !

I’m hopeful they do pull this off, as the strategy is starting to form and can see its potential or a continuous feedback loop.

No chance this will be anything more than a pump and dump. Company has no solid fundamentals, doesn't actually know what it's doing as a business and feels like people with too much money trying to get rich by throwing macaroni at the wall!

His investment handler sold, a long time ago - https://bmmagazine.co.uk/news/david-beckham-sells-stake-in-troubled-cbd-venture/?amp

Realistically this stock trades in news hype / momentum... But it has very little following, it's market cap makes it essentially a non starter.

Failed previous endeavour with incompetent leaders, reshifted to a product that is essentially a glorified Google chat bot and not particularly impressive.

Followed up by their latest move, which they are late to, overall a minor factor and with two stroke outs on previous business there's little to no confidence in it.

I'm not intentionally trying to be a "De-ramper" but these are simply facts, the company itself essentially does nothing, it now holds bitcoin and it's trying to use the subnet and bitcoin raising price to ensure it has funds... But it still essentially does... Nothing

This is a nice bit of information, although I don't think they'd be able to market it in their products directly, it does provide avenues for potential future expansion.

I do not believe the company is able to make any medical claims on their product in terms of direct treatment of conditions, as the item's sold are consider supplementary / health care and not medicinal. But, if the findings are peer reviewed and the science is good, it does pave a potentially valid avenue for new customers based on their own reading / findings.

Hopefully something good comes from it!

I second that thank you for the information, I looked into it and thought I had understood it but wasn't aware of the close of play factor!

Since there have been two calls for it and then extension, could that indicate two separate periods of large movement - Buy or Sell, where these transactions have taken place? Or is it simply re-iterating that it has occurred?

Many thanks!

I don't believe they'll make record sales in December, you are quite right that it may be too late to get the "Burst" of the Christmas sales. My point is I don't believe their sales will be dismal, I think they'll do reasonably well and potentially there is a bigger sale Opportunity post Christmas. The company is a long term play because its going to take time for the brand to be proven, become recognisable and hold itself within the market.

It's a waiting game, speculation is all we can do but I don't think the December sales will be a complete slump. It isn't likely to be this explosive rocket into space for the company, but overall I think there will be a steady growth going into 2022 which will creep up as the year progresses.

Not sure on how to filter, but you are right. People will be buying face creams & Cosmetics, although typically I believe they buy a brand the person recognises or frequently uses. However, the products coming out will have the novelty factor to boost the sales I believe. There are so many factors as to how well the sale of the product will do, but overall I think it will do just fine.

I get the impression some people holding are losing their patience, but let's be real, investments such as this one are a long play, if they struggle to hold their nerve or are frustrated over no quick returns then should avoid these types.

The latest tweet seems to give a bit more of an indication of the product range potentially, I wasn't sure how much they mentioned before but it seems to be:

A Serum
Face Oil
After Shaving Moisturiser

https://twitter.com/CellularGoods/status/1453379086458490893 - Post for reference

Cellular Good's is one of my first big time investments, I came in a few months back and have an average price of 6.9p, they're by far my largest shares in total investment. It'll be a long burner I think, some will jump the minute the price reaches a certain threshold but if sales are good and they keep to their current performance in terms of following the legislative requirements and diversifying their product range I think they'll prosper.

Indeed, we will definitely see the SP climb upon product release. Given the market space and current environment I have a feeling there are "Bigger players" out there watching. I think the SP will drop off a little after release until we have the first statement of earnings or more product release. Hopefully what we'll have is a spike in SP and then a new foundation SP level to build upon. Environment and following the rules are very important to the company which is a good thing.

Hopefully they'll be able to adapt to legislative changes (Whether they be restrictive or releasing). Excited to get some firm information on the exact product they'll be releasing - Price, Quantities, Packaging/design, Varieties perhaps? E.g face cream, hand palm etc. Plenty of excitement to be had it's just a case of holding out and being realistic with what is to come. The leadership of relative departments in the company itself seem to have some pretty impressive credentials, so overall not too worried about the long term of the companies health.

I think the main thing about this company and the market is that they're taking a newly emerging trend and trying to apply it to established markets. Established being cosmetics, supplements, Pet remedies etc, but with the added effects & science of Cannabinoids. The positive effects of these have been known for sometime, but legislation and public perception to a degree has hampered its use. I think their pathway of trying to educate on the product alongside selling it for its benefits will be a good approach.

An extra bonus is they're producing their components using a low emissions method, via synthesis production vs Warehouse, Greenhouse & Open field production. Given the recent climate information and countries trying to cut emissions, it puts them in a good stance for that and avoids any overhaul/transition in order to reduce those emissions (Vs other suppliers who use grown / warehouse produced). Public opinion seems to be growing for a greener/sustainable production line in various industries.

For reference on emissions, I am referring to this tweet: https://twitter.com/CellularGoods/status/1396426812847185921/photo/1

Expru200
I agree, I think this company will do well due as they're fledgling out into a new industry in the UK, but don't think Grodan's question was directed with hostility, more so he was just curious as to what insight you held! It's important for those of us invested in the company to recognise that they haven't sold a product yet. Their premise is good, overall they have good backing, but we will only really know how well they're doing in the long run after their results, balance sheets and revenue information becomes available post sales. I reckon we'll see a spike at the launch of products as expected, and then a more tempered response of either upwards or slight decline before bounce back as more details become available. I'm happy holding my shares in the long run and to hopefully see this company do really well!